Millions of people have this silent disease, without knowing it.

About 18 million of North Americans live with the Steatohepatitis. Those who suffer from type 2 diabetes, insulin resistance and obesity are more likely to be affected. This disease is difficult to diagnose and treat. Most people have never even heard about it.

If we are affected by the steatohepatitis non-alcoholic or steatohepatitis metabolic, commonly known as ” fatty liver“, it is that the fat accumulates in the cells of the liver. The disease is as debilitating as its alcoholic form. Here are the main symptoms and causes of this disease.

It is very common to have fat in the liver – this is the case of 70 million North Americans. In most, however, the accumulation of fat does not trigger dangerous health problems on the vital plane. In non-alcoholic steatohepatitis, liver inflammation is such that it can cause permanent scarification of tissues that lead to cirrhosis and an increased risk of hepatic cancer. Some researchers believe that, by 2020, this disease will exceed infectious hepatitis for liver transplants. Make sure you know the silent symptoms of liver cancer.

Why have doctors and patients ignored this dangerous disease for so long? “Because we didn’t see her,” said Business insider Mark Pruzanski, P.D.-G. of Intercept Pharmaceuticals, a company that targets liver ailments.

Very few symptoms are seen in the early stages. To identify this disease, a liver biopsy should be done (taking samples with a small needle). Even there, it could be too late: the disease often causes liver failure and there is currently no treatment.

The good news is that you can prevent non-alcoholic steatohepatitis by losing weight and adopting a healthy diet and weight. In addition, doctors and pharmaceutical companies are looking for treatment. There are currently clinical trials on a drug that is expected to be approved by the FDA in 2019.

If you are diabetic and need to lose weight, your risk of non-alcoholic steatohepatitis is increased. But you can try our anti-diabetes regime to stop its evolution.